Clinical Trials Directory

Trials / Terminated

TerminatedNCT00796627

Hypoxia-inducible Factor-1 (HIF-1) Regulated Circulating Angiogenic Cells (CACs) Recruitment in Burn Wound Healing

HIF-1 Regulated Circulating Angiogenic Cell Recruitment in Burn Wound Healing

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
Johns Hopkins University · Academic / Other
Sex
All
Age
14 Years – 75 Years
Healthy volunteers
Accepted

Summary

This research is being done to increase knowledge about wound healing and different factors that may affect healing in burn patients.

Detailed description

Burn injuries represent a major public health problem, requiring medical attention for more than one million Americans annually. Despite therapeutic advances, non-healing burn wounds and excessive scarring still result in significant long term physical and psychosocial morbidity. In this study we propose to perform clinical and research to study the role of circulating angiogenic cells (CAC) in promoting burn wound healing. CAC's have been shown to contribute to vascularization and tissue repair in a number of animal models of tissue injury ischemia and mobilization of CACs into the peripheral blood has been demonstrated in burn wound patients. We hypothesize that primary healing of burn wounds is dependent on repair of damaged vasculature, and that bone marrow derived stem cells, circulating angiogenic cells (CAC), play a critical role in the healing process. Furthermore we propose that the transcription factor Hypoxia Inducible Factor 1 alpha (HIF 1 alpha) through production of peptide products of its downstream target genes directs the "homing" of CAC's to the wound where they participate in healing events. The first aim of this study is to correlate mobilization of CAC's into the blood stream with the success of burn wound healing. CAC's have been shown to contribute to vascularization and tissue repair in a number of studies. The relationship between mobilization of CAC's and burn wound healing has not been examined. In addition to surveying CAC numbers in the peripheral blood, we will assay levels of the putative mediators of CAC mobilization: Vascular Endothelial Growth Factor (VEGF), Placenta Growth Factor (PLGF), and Stromal Cell-Derived Factor (SDF-1). We hypothesize that individuals who are able to mount a large and sustained mobilization of CAC's into the peripheral blood from the bone marrow, will be more likely to heal the injured vasculature and go on to primary healing. Individuals with an inadequate mobilization of CAC's will fail to repair the damaged vasculature in the wound and proceed to necrosis and "conversion" to third degree, necrotic burn wounds.

Conditions

Interventions

TypeNameDescription
GENETICHealthy volunteersComparison of healthy volunteers to burn wounded volunteers
OTHERBurn volunteersComparison of burn wounded volunteers to healthy volunteers

Timeline

Start date
2006-12-01
Primary completion
2014-04-01
Completion
2014-04-01
First posted
2008-11-24
Last updated
2017-09-29
Results posted
2017-09-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00796627. Inclusion in this directory is not an endorsement.